Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biofrontera (BFRI) Non Operating Income (2020 - 2025)

Biofrontera has reported Non Operating Income over the past 6 years, most recently at $632000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income rose 192.8% year-over-year to $632000.0; the TTM value through Dec 2025 reached $741000.0, up 161.7%, while the annual FY2025 figure was $388000.0, 173.62% up from the prior year.
  • Non Operating Income for Q4 2025 was $632000.0 at Biofrontera, up from $30000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $8.7 million in Q1 2022 and troughed at -$15.1 million in Q4 2022.
  • A 5-year average of -$605350.0 and a median of $500.0 in 2021 define the central range for Non Operating Income.
  • Biggest five-year swings in Non Operating Income: skyrocketed 174120.0% in 2022 and later plummeted 7722.73% in 2023.
  • Year by year, Non Operating Income stood at -$12.6 million in 2021, then decreased by 19.68% to -$15.1 million in 2022, then soared by 131.45% to $4.8 million in 2023, then crashed by 114.34% to -$681000.0 in 2024, then soared by 192.8% to $632000.0 in 2025.
  • Business Quant data shows Non Operating Income for BFRI at $632000.0 in Q4 2025, $30000.0 in Q3 2025, and -$264000.0 in Q2 2025.